# US 2026/0092325 A1 · Compositions and methods for sample analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092325 A1
- Document ID: US20260092325A1
- Status: Published application
- Kind: A1
- Application number: 19/341,966
- Filed: 2025-09-26
- Published: 2026-04-02
- Earliest claimed: 2024-09-27
- Applicants: 10x Genomics, Inc.
- Inventors: Connor KUNIHIRO; Layla KATIRAEE; Zachary W. BENT
- Web page: https://patentgrep.com/patent/US20260092325A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 2600/154: Methylation markers
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are systems and methods for analyzing nucleic acids. The present disclosure relates in aspects to methods of detecting an RNA molecule suspected of having a modified nucleotide. The method can further comprise detecting a location of the modified nucleotide on the RNA molecule.

## Claims

### Claim 1

A method comprising:
(a) providing:
(i) an RNA molecule suspected of having a modified nucleotide;
(ii) a binding agent coupled to an adapter, wherein the binding agent is configured to couple to the modified nucleotide;
(iii) a reverse transcriptase; and
(iv) a nucleic acid barcode molecule comprising a barcode sequence;
(b) partitioning, into a partition, the nucleic acid barcode molecule, the RNA molecule, and the reverse transcriptase;
(c) using the nucleic acid barcode molecule, the RNA molecule, and the reverse transcriptase to generate a barcoded nucleic acid molecule;
(d) using the binding agent coupled to an adapter and the barcoded nucleic acid molecule to generate a nucleic acid molecule coupled to the adapter if the RNA molecule comprises the modified nucleotide; and
(e) detecting the nucleic acid molecule coupled to the adapter or an amplification product thereof if the RNA molecule comprises the modified nucleotide.

### Claim 2 (depends on 1)

The method of claim 1, further comprising detecting a location of the modified nucleotide on the RNA molecule.

### Claim 3 (depends on 1)

The method of claim 1, further comprising sequencing the nucleic acid molecule coupled to the adapter or an amplification product thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the modified nucleotide is a methylated nucleotide.

### Claim 5 (depends on 4)

The method of claim 4, wherein the modified nucleotide is an N6-methyladenosine (m6A).

### Claim 6 (depends on 1)

The method of claim 1, wherein the RNA molecule is a messenger RNA (mRNA), transfer RNA (tRNA), long non-coding RNA (lncRNA).

### Claim 7 (depends on 1)

The method of claim 1, further comprising providing a plurality of random priming sequences.

### Claim 8 (depends on 1)

The method of claim 1, further comprising providing a plurality of template switch oligonucleotides, wherein the template switch oligonucleotide hybridizes to at least a portion of the RNA molecule.

### Claim 9 (depends on 1)

The method of claim 1, wherein (b) further comprises priming and subjecting the RNA molecule to reverse transcription.

### Claim 10 (depends on 9)

The method of claim 9, wherein the reverse transcription comprises hybridizing a random priming sequence to at least a portion of the RNA molecule and extending the random priming sequence.

### Claim 11 (depends on 1)

The method of claim 1, further comprising generating a complementary DNA strand that is complementary to the RNA molecule and hybridizing the complementary DNA strand to the RNA molecule to generate an RNA-DNA duplex.

### Claim 12 (depends on 1)

The method of claim 1, wherein the binding agent comprises a Tn5 transposase.

### Claim 13 (depends on 12)

The method of claim 12, wherein the Tn5 transposase is fused to an m6A-specific antibody.

### Claim 14 (depends on 13)

The method of claim 13, further comprising using the antibody to bind to a N6-methyladenosine (m6A) on the RNA molecule, and the transposase binds to the RNA molecule and the complementary nucleic acid molecule.

### Claim 15 (depends on 12)

The method of claim 12, wherein the transposase comprises a nucleic acid barcode sequence unique to the m6A methylation feature.

### Claim 16 (depends on 1)

The method of claim 1, wherein the nucleic acid barcode molecule is coupled to a bead.

### Claim 17 (depends on 1)

The method of claim 1, wherein (b) further comprises the transposase in the partition.

### Claim 18 (depends on 1)

The method of claim 1, wherein (b) is subjected to temperature conditions or buffering conditions sufficient for tagmentation by the binding agent.

### Claim 19

A method comprising:
a. providing:
i. an RNA molecule suspected of having a modified nucleotide;
ii. a binding agent coupled to an adapter, wherein the binding agent is configured to couple to the modified nucleotide;
iii. an RNA ligase; and
iv. a nucleic acid barcode molecule comprising a barcode sequence;
b. partitioning into a partition, the nucleic acid barcode molecule, the RNA molecule, and the ligase;
c. using the nucleic acid barcode molecule, the RNA molecule, and the RNA ligase to generate a barcoded nucleic acid molecule;
d. using the binding agent coupled to the adapter to isolate the barcoded nucleic acid molecule if the RNA molecule comprises the modified nucleotide; and
e. detecting the barcoded nucleic acid molecule if the RNA molecule comprises the modified nucleotide.

### Claim 20

A method comprising:
a. providing:
i. an RNA molecule suspected of having a modified nucleotide;
ii. a nucleic acid barcode molecule comprising a barcode sequence; and
iii. an adenosine deaminase enzyme;
b. partitioning, into a partition the nucleic acid barcode molecule, the RNA molecule, and the adenosine deaminase enzyme,
c. using the nucleic acid barcode molecule, the RNA molecule, and the adenosine deaminase enzyme to generate a barcoded nucleic acid molecule if the RNA molecule comprises the modified nucleotide; and
d. detecting the barcoded nucleic acid molecule.
